Oncology Conferences | Cancer Meetings | USA | Europe | Middle East | Asia Pacific

Theme: Welcoming the era of multiplying smiles not Cancer cells

Oncologists 2018

Scientific Program

Renowned Speakers

Jacob Gopas
Ben Gurion University of the Negev
Israel

Kazuko Tatsumura
Gaia Holistic Health
USA

Celestial T Yap
National University of Singapore
Singapore

Yun Seong Kim
Pusan National University
South Korea

Shuo Deng
National University of Singapore
Singapore

Mei-Ren Pan
Kaohsiung Medical University
Taiwan

Yu-Chieh Lee
Taipei Medical University Hospital
Taiwan

Hydelene B Dominguez
Saint Louis University - Hospital of the Sacred Heart
Philippines

Chi-Wen Luo
Kaohsiung Chang Gung Memorial Hospital
Taiwan

Neelum Aziz Yousafzai
Zhejiang University
China

Oncologists 2018

Dear Colleagues and Scientists,

Welcome to the 22^nd Global Annual Oncologists Meeting

Probably for many of you this is the first time you come to this stimulating environment. This modern city of Osaka is certainly the right place to envision the future with optimism the attitude we should have trying to think about new approaches to the cure of cancers.

Some people believe we are at a momentum in cancer research because politicians yet again decided to push for what is called a “moon shot” type of approach. We heard about this before. Anyway with or without moon shot huge progresses have been made; 90% of children with leukemia are now cured and cures are obtained in other type of cancers. I am impressed with the variety of new attempts being done in the treatment of cancers. Some work in some patients but not in others showing the heterogeneity of neoplastic disease.

But politicians do not realize the gigantic task facing us because we are not dealing with one disease, but several diseases. There are apparently simple concepts that have not been solved. Many years after the discovery of oncogenes there is still no agreement about their mechanism of action. Another old problem is the relationship between cancer and aging. Many people still claim that aging is a factor favoring the emergence of cancers although there is no evidence whatsoever supporting the association.

Breast cancers have become increasingly more common in younger women, maybe in part due to the delay in childbirth. I remember about 20 years ago an eminent scientist mentioning this fact and telling: what are you doing there seating and waiting for the answer? We are still waiting for the answer. In France the number of women with breast cancers has significantly increased in the group 30-49 years old nobody knows why. The increase is such that some people speak about an epidemic. On the other hand it has decreased in the 50-79 years group.

No significant progress is made about prevention, sometimes because of economic interests. This is a field where with decisive action a significant progress could be made; 40% of cancers could be avoided with a change of the way of life, inter alia tobacco, alcohol, nutrition, physical activity, and environmental pollution. So on one hand treatment has improved for some cancers but the incidence has increased for other cancers. Making a long story short, you probably will not go home from this meeting with any answers, but if you go home with many questions, it will have been worthwhile coming over.

Alvaro Macieira-Coelho

Research Director

French National Institute of Health (INSERM)

France

ConferenceSeries llc LTD invites all the participants across the globe to attend the "22^nd Global Oncologists Annual Meeting” slated on 22nd Global Annual Oncologists Meeting” during May 24-25 at Osaka, Japan

Theme: Welcoming the era of multiplying smiles not Cancer cells

Oncologists 201 8 directs towards addressing main issues as well as future strategies of Cancer.This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumour immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Oncologists Meeting at Cologne, Germany will deal with Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 will also provide the three days of discussions on methods and strategies related to management and quality improvement of Cancer and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukemia, blood cancer, cervical cancer, colon-rectum cancer, pediatric cancer, surgical cancer, Prostate cancer, thyroid cancer. In Dubai on an average of 7% of the people caused to death with Cancer every year and Lung Cancer, Blood Cancer, Breast Cancer are most common Cancers in Dubai.

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increasein the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it.

ConferenceSeries llc LTD which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. ConferenceSeries llc LTD hosts numerous Cancer Conferences,Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists community, oncology society, European oncology conferences, American oncology society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience

· Oncologists

· Radiologists

· Pathologists

· Hematologists

· Academicians

· Research Scholars

· Students

· Hematology Associations & Societies

· Business Entrepreneurs

· Software Developing Companies

· Medical Devices Companies

· Biomedical Companies

· Biotechnology Companies

· Data Management Companies

ConferenceSeries llc LTD invites all the participants from all over the world to attend “22^nd Global Annual Oncologists Meeting” during May 24-25 at Osaka, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Oncologists 2016 is the sequel of the past Oncology Conferences.

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists Community, Oncology Society, European Oncology Conferences, American Oncology Society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

ConferenceSeries llc LTD, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

A step towards Cancer free World, the theme of the upcoming Oncologists Meeting directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized by ConferenceSeries Ltd. This Oncologists Meeting will have three days of discussions on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The following are the scientific sessions has been designed for the upcoming Oncologists Meeting

Oncology

Oncology is a branch of medicine that deals with tumours. A medical professional who practices oncology is an oncologist. Integrative oncology manages the mind, body, and spirit. Modalities of movement, touch, nutrition, and mindfulness are used within conventional cancer care to address and improve symptoms and quality-of-life. That is why many practitioners, including medical doctors, have embraced the rapidly expanding field of integrative oncology, which fuses the best of conventional and alternative treatments.Immuno-oncology therapies activate our immune system, making it able to recognise cancer cells and destroy them. Since cancer cells are very different from normal cells in the body, the immune system attacks them when it is able to recognise them. Neuro-oncology evaluates and treats people with primary and secondary tumours of the brain, spinal cord, and the membranes surrounding the brain and spinal cord (meninges). Oncologic Emergencies, as the term implies, are complications resulting from a cancer itself, a paraneoplastic syndrome, or from treatment of cancer that require immediate attention and reversal, if possible. Inpatient treatment is a must, and often these conditions require intervention in an intensive care setting.

22^ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan;; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; 9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; International Conference on Cancer Diagnostics 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Clinical Oncology

Clinical Oncology includes Medical Oncology (MO), Surgical Oncology (SO), Gynecologic Oncology, Hematologic Malignancies .Medical oncology communicates the results of clinical and experimental research in oncology and haematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist specializes in the removal of the tumours and surrounding tissue during an operation. A surgical also performs biopsies (the removal of a small amount of tissue for examination under a microscope). Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Werner syndrome (WS), also known as "adult progeria is a rare, autosomal recessive progeroid syndrome (PS), which is characterized by the appearance of premature aging. Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

22^ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Pediatric Oncology

Pediatric oncologists are the physicians who have specialized in pediatrics and then received further training in medical oncology and hematology. This means that rather than using surgery or radiation therapy to treat cancer, pediatric oncologists typically use medications and chemotherapy. Myeloid leukemia is a type of leukemia affecting myeloid tissue. In medicine, histiocytosis refers to an excessive number of histiocytes, (tissue macrophages), and is typically used to refer to a group of rare diseases which share this as a characteristic. Occasionally and confusingly, the term "histiocytosis" is sometimes used to refer to individual diseases. Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL) is an acute form of leukaemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts. A brain tumour or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumours: malignant tumours and benign tumours.

2^nd Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2^nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Radiation oncology

Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A Radiation Oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Brachytherapy is an advanced cancer treatment. Radioactive seeds or sources are placed in or near the tumour itself, giving a high radiation dose to the tumour while reducing the radiation exposure in the surrounding healthy tissues. External beam therapy (EBT), also called external radiation therapy, is a method for delivering a beam or several beams of high-energy x-rays to a patient's tumour. Intraoperative radiation therapy, or IORT is the application of therapeutic levels of radiation to the tumour bed while the area is exposed during surgery. Systemic radiation therapy is a type of radiation therapy in which radioactive material travels through the bloodstream to reach cells all over the body. Systemic radiation is used to treat certain types of cancer, such as thyroid cancer, or to relieve pain when cancer has spread (metastasized) to the bone. Radio immunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumour-associated antigen is used to deliver a lethal dose of radiation to the tumour cells.

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.

Hematologic Oncology

Hematologic oncology: The diagnosis, treatment and prevention of blood diseases (hematology) and cancer (oncology) and research into them. Hematologic oncology includes such diseases as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemia’s, leukaemia and lymphomas, as well as cancers of other organs. Tumours of the hematopoietic and lymphoid tissues or haematopoietic and lymphoid malignancies are tumours that affect the blood, bone marrow, lymph, and lymphatic system. Plasma cell dyscrasias are disorders of the plasma cells. Plasma cell dyscrasias are produced as a result of abnormal proliferation of a monoclonal population of plasma cells that may or may not secrete detectable levels of a monoclonal immunoglobulin or immunoglobulin fragment (paraprotein or M protein). Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made. Myelodysplastic or myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many white blood cells. Both Hodgkin's lymphoma and non-Hodgkin's lymphomaare lymphomas, a type of cancer that begins in a subset of white blood cells called lymphocytes.

Chemotherapy

Chemotherapeutic agent an agent used to treat cancer administered in regimens of one or more cycles, combining two or more agents over a period of days to weeks. Intravenous chemotherapy is one way to receive cancer-fighting medicine. Oral chemotherapy (chemo) is a treatment used to shrink a tumour or kill cancer cells. Oral chemo is usually taken in the form of a pill or capsule. Arterial chemotherapy infusion of the liver and chemoembolization of the liver (transarterial chemoembolization or TACE) are similar procedures that are used for the treatment of cancers in the liver. Adjuvant therapy or care, also called adjunct therapy or adjunctive therapy or care, is therapy that is given in addition to the primary, main, or initial therapy to maximize its effectiveness. Topical chemotherapy is a cream or lotion applied directly to the skin cancer. Different drugs cause different side effects. Certain types of chemotherapy often have specific side effects. But, each person’s experience is different.

Oncologists

Oncologists are doctors who specialize in treating people with cancer. They are responsible for the care of a patient from the moment of a cancer diagnosis throughout the course of the disease. A medical oncologist specializes in treating cancer with chemotherapy such as targeted therapy and oral (in pill form) chemotherapy. A surgical oncologist specializes in the removal of the tumour and surrounding tissue during an operation. And a radiation oncologist specializes in treating cancer with radiation therapy (the use of high-energy x-rays or other particles to kill cancer cells).

Organ Specific Cancer

Brain and spinal cord tumours may be either benign (not cancer) or malignant (cancer).Both benign and malignant tumours cause signs and symptoms and need treatment. Benign brain and spinal cord tumours grow and press on nearby areas of the brain but rarely spread into other parts of the brain. Malignant brain and spinal cord tumours are likely to grow quickly and spread into other parts of the brain. The bones around the nasal cavity have small hollow spaces in them called paranasal sinuses. These sinuses affect the sound and tone of voice. The exact causes of nasal and sinus cancers are not known. Cancers that are known collectively as head and neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). The most dangerous form of skin cancer is these cancerous growths develop once unrepaired DNA damage to skin cells most frequently caused by ultraviolet radiation from sunshine or tanning beds triggers mutations genetic defects that lead the skin cells to multiply rapidly and form malignant tumors. Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Pulmonary metastases of renal cell carcinoma (RCC) are associated with poor prognosis. Inhalation therapy with interleukin-2 (IL-2) is thus an appealing method for palliation. Carcinoma of the thyroid gland is an uncommon cancer but is the most common malignancy of the endocrine system. Differentiated tumours (papillary or follicular) are highly treatable and usually curable. Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitis infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of liver cirrhosis). Reproductive cancers start in the organs related to reproduction. These organs are located in the pelvis. The pelvis is the area in the lower belly between the hip bones.

Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain;

Cancer: Causes

Metastasis, or metastatic disease, is the spread of a cancer or other disease from one organ or part to another not directly connected with it. An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called on coronaviruses to denote their RNA virus origin. Carcinogenesis or oncogenesis or tumorigenesis is the actual formation of a cancer, whereby normal cells are transformed into cancer cells . Mutagenesis is a process by which the genetic information of an organism is changed in a stable manner, resulting in a mutation. It may occur spontaneously in nature or as a result of exposure to mutagens. Apoptosis is a form of physiological cell death mediated by caspases, a unique family of intracellular cysteine proteases.

Cancer: Diagnostics and Staging

X-radiation (composed of X-rays) is a form of electromagnetic radiation Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. An ultrasound scan, sometimes called a sonogram, is a procedure that uses high-frequency sound waves to create an image of part of the inside of the body. A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist involving sampling of cells or tissues for examination. A complete blood count (CBC) gives important information about the kinds and numbers of cells in the blood, especially red blood cells camera.gif, white blood cells camera.gif, and platelets. Cancer staging is the process of determining the extent to which a cancer has developed by spreading. The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that gives codes to describe the stage of a person's cancer, when this originates with a solid tumour. Pathologic staging, where a pathologist examines sections of tissue, can be particularly problematic for two specific reasons: visual discretion and random sampling of tissue.

Cancer: Treatment and Therapy

Various therapeutics are now available to treat cancer.. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature due to failed thermoregulation that occurs when a body produces or absorbs more heat than it dissipates.

Cancer Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis. The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,;World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA.

Cancer and Pharmacology

Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nano medicine desires to deliver research tools and clinically reformative devices in the near future.The clinical toxicology importance of any drug interaction depends on factors that are drug-patient and administration related. Generally, a doubling or more in plasma drug concentration has the potential for enhanced adverse or beneficial drug response Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticanceragents. Interactions with other medications can causes small changes pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity.

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

Cancer: Vaccines and Prevention

Cancer Vaccines help the body’s immune system prepare for future attacks. Vaccines consist of killed or modified microbes, parts of microbial DNA that trick the body into thinking an infection has occurred. A prophylactic vaccination is a selective exposure to a weakened or diluted form of an infectious agent to encourage a patient to form antibodies. Vaccination given during childhood is generally safe. Adverse effects if any are generally mild. The rate of side effects depends on the vaccine in question. Some common side effects include: fever, pain around the injection site, and muscle aches. Additionally, some individuals may be allergic to ingredients in the vaccine. MMR vaccine is rarely associated with febrile seizures.Cancer Prevention or chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. Screening, in medicine, is a strategy used in a population to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms. The effect of diet and nutrition on cancer prevention and recurrence (the return of cancer after treatment) is one of the most studied topics in medicine.

9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK

Cancer Prognosis

Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. These stats often use an overall five-year survival rate are supported on research from information gathered on hundreds or thousands of individuals with a particular cancer. An overall existing rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed extremely early and people diagnosed terribly late.

Cancer and Alternative Medicine

AYUSH system is the most common term used for the cancer treatment. Ayurvedic medicine is an ancient Indian system of medicine which began about 5,000 years ago. It is not just one treatment. It is a way of diagnosing illness and using a wide range of treatments and techniques. Herbal medicine uses plants, or mixtures of plant extracts, to treat illness and promote health. It aims to restore your body's ability to protect, regulate and heal itself. It is a whole body approach, so looks at your physical, mental and emotional wellbeing. It is sometimes called phytomedicine, phytotherapy or botanical medicine. Naturopathic doctors (NDs) believe that cancer arises from an imbalance that causes a systemic breakdown within the body. Homeopathy is based on the theory of treating like with like. So to treat an illness a homeopathic therapist (homeopath) uses tiny doses of a substance that in large doses would actually cause the symptoms of the illness.

9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan.

Economic Impact on Cancer

Distribution in economics refers to the way total output, income, or wealth is distributed among individuals or among the factors of production (such as labour, land, and capital). In general theory and the national income and product accounts, each unit of output corresponds to a unit of income. Cancer can be a major cause of lack of money. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The study is a longitudinal short study of 10,000 hospital patients with a first time diagnosis of cancer. Patients were assigned a socioeconomic status according to the district of residence at diagnosis. Continuity of patients due to cancer living in the most deprived district was compared to survival of patients living in all other districts by model-based period analysis. These major regional socioeconomic inequalities indicate a potential for improving cancer care and survival in Germany. Studies on individual patient data with access to cancer treatment information should be conducted to examine the reasons for these socioeconomic inequalities in cancer survival in more detail.

International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain.

Oncology Case reports

Globally it is expected that there are 7.6 million new cancer cases per annum, out of which 52% happen in developing countries. Cancer case reports should include relevant positive and negative findings from history, examination and investigation, and can include clinical photographs; provided these are accompanied by written consent to publish from the patient(s).Case reports should include an up-to-date review of all previous cases in the field.

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th International Cancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th World Congress on Cancer Therapy (977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers August 23-24, 2017 Birmingham, UK;16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; Global Summit on Oncology & Cancer, May 25-27, 2017 Osaka, Japan,; International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 24-25, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai UAE It was highly informative meeting. I was surprised with such organization and arrangement. I met some figures who had inspired me. I came across with a dozen of ideas that can easily implement in clinical research.
Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia

It was a good conference and all the speakers gave very clear presentations.I think this is very worth full conference.
Diana Anderson, University of Bradford, UK

The conference was organized perfectly. I would like to thank organiser for excellent hotel,congress programme, certificate, materials. Thank you for the warm hospitality.
Sonya Sergieva, Sofia Cancer Center Sofia, Bulgaria

The conference was well arranged , good place , good time , good interval , excellent articles by professional researchers .
Jaleel Kareem Ahmed, Babylon University, Iraq

Thank you for the greeting and we do learn a lot form this meeting
CSLin,National University,Taiwan

I am glad to participate at this great meeting with very interesting talks from physician and expertise all over the world, and I have enjoyed each and every sessions.
Stephanie Notttrott, Isenbruck BÃ¶sl HÃ¶rschler LLP, Germany

Thanks for arranging such amazing meeting.I am lucky to be one of the speaker in the meeting.
Wen-Lung Ma, China Medical University Hospital, Taiwan

I am very pleased about this conference because the session designed was based upon both scientific and in general and mode where we can discuss and express our views about it, I love and appreciate this type of conferences.
Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation

The conference was very interactive and quite interesting, as I have come from all the way from north Carolina to attend this conference, I have enjoyed every bit of learning new sciences in the field of oncology which is my research field. I am very grateful to the organiser especially omics for inviting me and giving me a chance to present my research work here.
HirendraNath Banerjee,Elizabeth City State University, USA

22^nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Oncologists 2018

Dear Colleagues and Scientists,

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Useful Links

Special Issues

Testimonials